Streetbeat News

Analyst Ratings

CLB

Piper Sandler analyst Luke Lemoine maintains a Neutral rating on Core Laboratories (NYSE:CLB) and raises the price target from $19 to $21.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:28 pm

CINF

Piper Sandler analyst Paul Newsome maintains a Neutral rating on Cincinnati Financial (NASDAQ:CINF) and raises the price target from $113 to $117.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:28 pm

CHDN

B of A Securities analyst Shaun Kelley maintains a Buy rating on Churchill Downs (NASDAQ:CHDN) but lowers the price target from $155 to $142.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:25 pm

ACAX

ACHR

GDRX

SILC

UFAB

YELL

U.S. stocks traded slightly higher with the Nasdaq Composite gaining around 20 points. Energy shares climbed by 2.1% while health care shares fell by 1%. Yellow Corporation (YELL) shares shot up 88% after terminating its operations. GoodRx Holdings (GDRX) shares rose 36% after an upgrade from TD Cowen. Archer Aviation (ACHR) shares gained 34% after entering into contracts with the US Air Force. Unique Fabricating (UFAB), Alset Capital Acquisition Corp. (ACAX), and Silicom Ltd. (SILC) shares dropped.

Portfolio Pulse from Lisa Levin

July 31, 2023 | 4:25 pm

GS

SPY

Goldman Sachs' Prime Brokerage report indicates that long/short hedge funds are on track to experience the worst monthly alpha drawdown since May 2022. The firm believes signs of capitulation are starting to emerge.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 4:24 pm

GS

SPY

Goldman Sachs' Prime Brokerage report indicates that hedge funds de-risked in July at nearly record levels for the past decade, primarily due to short covering. Long/short hedge funds saw nine consecutive days of negative returns before July 28.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 4:23 pm

CUBI

Maxim Group analyst Michael Diana maintains a 'Buy' rating on Customers Bancorp (NYSE:CUBI) and raises the price target from $45 to $55.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:23 pm

MLTX

Wedbush analyst Andreas Argyrides has maintained an Outperform rating on MoonLake (NASDAQ:MLTX) and raised the price target from $61 to $86.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:22 pm

MDC

Wedbush analyst Jay McCanless has maintained a Neutral rating on M.D.C. Holdings (NYSE:MDC) and raised the price target from $28 to $51.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:21 pm

GTLS

Craig-Hallum analyst Eric Stine maintains a 'Buy' rating on Chart Industries (NYSE:GTLS) and raises the price target from $208 to $234.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:19 pm